SCRN1, identified to have effects on bipolar disorder, is a novel phosphorylated tau binding protein that has been shown to be abundant in amyloid plaques [66] and has been recently identified as shared in cross-trait analyses between bipolar disorder and inflammatory bowel disease [67]. This evidence concerns the gene SCRN1 and inflammatory bowel disease.